Ozempic Could Be Used to Treat Alcohol and Drug Addiction
23 hours ago · In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new ...
Research shows GLP-1 drugs are effective but complex - UChicago …
May 30, 2024 · While experts caution against overusing GLP-1RAs or viewing them as a universal cure-all for obesity, physicians and researchers agree that the drugs are highly effective for weight management and Type 2 diabetes treatment.
Expanding Access to Weight-Loss Drugs Could Save Thousands of …
2 days ago · Recent advancements in pharmaceutical interventions however, particularly the introduction of glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic and Wegovy, and dual gastric inhibitory polypeptide and GLP-1 (GIP/GLP-1) receptor agonists, such as tirzepatide, have demonstrated substantial efficacy in weight loss. These ...
Special Report: Potential Strategies for Addressing GLP-1 and Dual …
Apr 7, 2023 · Unexpected drug shortages of the long-acting glucagon-like peptide 1 (GLP-1) receptor agonists dulaglutide and semaglutide and the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist tirzepatide emerged in late 2022 and have persisted through the first quarter of 2023 .
Harvard Medical School Researcher Wins 2024 Lasker Award for …
Sep 19, 2024 · Harvard Medical School researcher Joel Habener has won the 2024 Lasker~DeBakey Clinical Medical Research Award for his discovery of glucagon-like peptide-1 (GLP-1), a molecule that has become the basis for therapies which have transformed the treatment of obesity.
Summary of Glucagon-like Peptide-1 Receptor Agonists for Adults
Jun 29, 2023 · Glucagon-like peptide-1 (GLP-1) receptor agonists are approved by the Food and Drug Administration for treatment of type 2 diabetes mellitus and cardiovascular risk reduction in this cohort (see table). 1 In addition, GLP-1 receptor agonists are also used for weight loss.
FDA approves first oral GLP-1 treatment for type 2 diabetes
Rybelsus is the first glucagon-like peptide (GLP-1) receptor protein treatment approved for use in the United States that does not need to be injected.
After GLP-1, what’s next for weight loss? - Nature
Jun 6, 2023 · Wegovy mimics the effects of glucagon-like peptide 1 (GLP-1), a hormone released by the gut’s L cells in response to food. GLP-1 stimulates pancreatic cells to release insulin and lower blood...
Glucagon-like peptide-1 receptor: mechanisms and advances in …
Sep 18, 2024 · The glucagon-like peptide-1 (GLP-1) receptor, known as GLP-1R, is a vital component of the G protein-coupled receptor (GPCR) family and is found primarily on the surfaces of various cell...
Pfizer Announces Topline Phase 2b Results of Oral GLP-1R …
Dec 1, 2023 · NEW YORK-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced topline data from the Phase 2b clinical trial (NCT04707313) investigating its oral Glucagon-like peptide-1 receptor agonist (GLP-1RA) candidate, danuglipron (PF-06882961), in adults with obesity and without type 2 diabetes.